Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S recorded five transactions d'initiés over the past ninety days, resulting in a net negative value of approximately 430,319 USD. Recent activity includes both acquisitions and divestments by corporate officers. These movements follow a strong performance in the latest earnings report, where the company exceeded expectations by over 321 percent.
Ticker: ASND Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ascendis Pharma A/S. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Bodenhoff Mads SVP & PAO Officer
Transaction date
Sale
Price
389.81
Quantity 2,440 +8.8%
Value US$4,593,162
Bodenhoff Mads Officer Officer
Transaction date
Proposed sale
Price
415.89
Quantity 15,039
Value US$1,408,326
HOLTUG LARS Non-Executive Director
Transaction date
Sale
Price
396.67
Quantity 54,068 -31.5%
Value US$1,174,717
HOLTUG LARS Director Non-Executive Director
Transaction date
Proposed sale
Price
264.13
Quantity 236
Value US$62,335
2.9
BIENAIME JEAN JACQUES Non-Executive Director
Transaction date
Purchase
Price
246.91
Quantity 900 +45.0%
Value US$222,219
2.9
BIENAIME JEAN JACQUES Non-Executive Director
Transaction date
Purchase
Price
245.85
Quantity 1,100 +122.2%
Value US$270,435
SMITH SCOTT THOMAS EVP & Chief Financial Officer Officer
Transaction date
Purchase
Price
219.00
Quantity 100 +2.3%
Value US$21,900
SMITH SCOTT THOMAS EVP & Chief Financial Officer Officer
Transaction date
Purchase
Price
223.32
Quantity 250 +6.2%
Value US$55,830
2.9
BIENAIME JEAN JACQUES Non-Executive Director
Transaction date
Purchase
Price
223.50
Quantity 100 +12.5%
Value US$22,350
2.9
BIENAIME JEAN JACQUES Non-Executive Director
Transaction date
Purchase
Price
222.30
Quantity 200 +33.3%
Value US$44,460
2.9
BIENAIME JEAN JACQUES Non-Executive Director
Transaction date
Purchase
Price
223.76
Quantity 200 +50.0%
Value US$44,752
2.9
BIENAIME JEAN JACQUES Non-Executive Director
Transaction date
Purchase
Price
239.37
Quantity 200 +100.0%
Value US$47,874
2.9
BIENAIME JEAN JACQUES Non-Executive Director
Transaction date
Purchase
Price
236.24
Quantity 200 +inf%
Value US$47,247
1.6
JENSEN FLEMMING STEEN See Remarks Officer
Transaction date
Sale
Price
238.49
Quantity 19,460 -100.0%
Value US$4,641,021
1.6
JENSEN FLEMMING STEEN Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY Officer
Transaction date
Proposed sale
Price
238.49
Quantity 19,460
Value US$4,641,022
SINGEL STINA Officer Officer
Transaction date
Proposed sale
Price
240.00
Quantity 3,782
Value US$907,680
Bodenhoff Mads Officer Officer
Transaction date
Proposed sale
Price
237.53
Quantity 10,000
Value US$2,375,308
SMITH SCOTT THOMAS Officer Officer
Transaction date
Proposed sale
Price
240.00
Quantity 10,000
Value US$2,400,000
Shu Aimee Officer Officer
Transaction date
Proposed sale
Price
235.81
Quantity 5,583
Value US$1,316,555
SMITH SCOTT THOMAS Officer Officer
Transaction date
Proposed sale
Price
240.00
Quantity 10,000
Value US$2,400,000
Jan Moller Mikkelsen CEO; Officer Officer
Transaction date
Proposed sale
Price
241.38
Quantity 94,000
Value US$22,689,720
Morrison Lisa Officer Officer
Transaction date
Proposed sale
Price
236.34
Quantity 10,105
Value US$2,388,195
Shu Aimee Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER Officer
Transaction date
Proposed sale
Price
239.22
Quantity 7,290
Value US$1,743,914
0.6
Fairey William Director Non-Executive Director
Transaction date
Proposed sale
Price
242.09
Quantity 1,800
Value US$435,762
IMANI SIHAM Director Non-Executive Director
Transaction date
Proposed sale
Price
242.09
Quantity 1,800
Value US$435,762
SMITH SCOTT THOMAS Officer; EXECUTIVE VP CHIEF FINANCIAL OFFICER Officer
Transaction date
Proposed sale
Price
242.09
Quantity 18,349
Value US$4,442,109
JENSEN MICHAEL WOLFF Officer; EXECUTUVE VP CHIEF LEGAL OFFICER Officer
Transaction date
Proposed sale
Price
242.09
Quantity 18,349
Value US$4,442,109
Bodenhoff Mads Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER Officer
Transaction date
Proposed sale
Price
242.09
Quantity 6,872
Value US$1,663,642
Morrison Lisa Director Non-Executive Director
Transaction date
Proposed sale
Price
242.09
Quantity 2,100
Value US$508,389
HOLTUG LARS Director Non-Executive Director
Transaction date
Proposed sale
Price
242.09
Quantity 2,100
Value US$508,389
SPROGOE KENNETT Officer; EXECUTIVE VP HEAD OF RESEARCH AND PROD DEVELOPMENT Officer
Transaction date
Proposed sale
Price
242.09
Quantity 10,800
Value US$2,614,572
1.6
JENSEN FLEMMING STEEN Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY Officer
Transaction date
Proposed sale
Price
242.09
Quantity 10,800
Value US$2,614,572
1.7
Cha Albert Director Non-Executive Director
Transaction date
Proposed sale
Price
242.09
Quantity 2,100
Value US$508,389
MIKKELSEN JAN MOLLER Officer; PRESIDENT CEO Officer
Transaction date
Proposed sale
Price
211.99
Quantity 86,860
Value US$18,413,631
JENSEN MICHAEL WOLFF Officer Officer
Transaction date
Proposed sale
Price
208.10
Quantity 10,000
Value US$2,081,019
Jan Moller Mikkelsen CEO; Officer Officer
Transaction date
Proposed sale
Price
210.85
Quantity 100,000
Value US$21,085,000
SPROGOE KENNETT Officer Officer
Transaction date
Proposed sale
Price
209.32
Quantity 10,000
Value US$2,093,222
1.6
JENSEN FLEMMING STEEN Officer Officer
Transaction date
Proposed sale
Price
205.85
Quantity 10,000
Value US$2,058,454
SINGEL STINA Officer Officer
Transaction date
Proposed sale
Price
209.54
Quantity 218
Value US$45,680
1.6
JENSEN FLEMMING STEEN Officer Officer
Transaction date
Proposed sale
Price
203.70
Quantity 5,000
Value US$1,018,503
JENSEN MICHAEL WOLFF Officer Officer
Transaction date
Proposed sale
Price
193.00
Quantity 5,000
Value US$965,000
Jan Moller Mikkelsen President and Chief Executive Officer Officer
Transaction date
Proposed sale
Price
192.80
Quantity 3,000
Value US$578,385
JENSEN MICHAEL WOLFF Officer Officer
Transaction date
Proposed sale
Price
194.82
Quantity 9,375
Value US$1,826,403
Morrison Lisa Director; Non-Executive Director Non-Executive Director
Transaction date
Proposed sale
Price
191.07
Quantity 2,158
Value US$412,319
1.6
JENSEN FLEMMING STEEN Officer Officer
Transaction date
Proposed sale
Price
191.32
Quantity 10,000
Value US$1,913,225
SMITH SCOTT THOMAS Officer Officer
Transaction date
Proposed sale
Price
192.57
Quantity 10,000
Value US$1,925,734
Shu Aimee Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER Officer
Transaction date
Proposed sale
Price
154.80
Quantity 2,018
Value US$312,384
1.6
JENSEN FLEMMING STEEN Officer Officer
Transaction date
Proposed sale
Price
162.20
Quantity 10,938
Value US$1,774,164
Shu Aimee Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER Officer
Transaction date
Proposed sale
Price
166.61
Quantity 4,204
Value US$700,412
SPROGOE KENNETT Officer Officer
Transaction date
Proposed sale
Price
170.05
Quantity 10,000
Value US$1,700,485
JENSEN MICHAEL WOLFF Officer Officer
Transaction date
Proposed sale
Price
170.99
Quantity 4,386
Value US$749,948
JENSEN MICHAEL WOLFF Officer Officer
Transaction date
Proposed sale
Price
146.46
Quantity 4,000
Value US$585,846
1.6
JENSEN FLEMMING STEEN Officer Officer
Transaction date
Proposed sale
Price
152.39
Quantity 10,000
Value US$1,523,933
JENSEN MICHAEL WOLFF Officer Officer
Transaction date
Proposed sale
Price
152.25
Quantity 1,614
Value US$245,735
MIKKELSEN JAN MOLLER Officer; PRESIDENT CHIEF EXECUTIVE OFFICER Officer
Transaction date
Proposed sale
Price
155.13
Quantity 7,789
Value US$1,208,292
Bodenhoff Mads Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER Officer
Transaction date
Proposed sale
Price
155.01
Quantity 2,254
Value US$349,403
Hartvig Camilla Harder Officer; EXECUTIVE VP AND CHIEF COMMERCIAL OFFICER Officer
Transaction date
Proposed sale
Price
152.12
Quantity 2,222
Value US$338,021
Bodenhoff Mads Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER Officer
Transaction date
Proposed sale
Price
152.12
Quantity 2,828
Value US$430,208
0.6
Fairey William Director Non-Executive Director
Transaction date
Proposed sale
Price
152.12
Quantity 1,006
Value US$153,037
IMANI SIHAM Director Non-Executive Director
Transaction date
Proposed sale
Price
152.12
Quantity 1,006
Value US$153,037
Morrison Lisa Director Non-Executive Director
Transaction date
Proposed sale
Price
152.12
Quantity 1,470
Value US$223,623
HOLTUG LARS Director Non-Executive Director
Transaction date
Proposed sale
Price
152.12
Quantity 1,470
Value US$223,623
1.7
Cha Albert Director Non-Executive Director
Transaction date
Proposed sale
Price
152.12
Quantity 1,470
Value US$223,623
SINGEL STINA Officer; EXECUTIVE VP HEAD OF CLINICAL DEV ONCOLOGY Officer
Transaction date
Proposed sale
Price
152.12
Quantity 13,344
Value US$2,029,949
SMITH SCOTT THOMAS Officer; EXECUTIVE VP CHIEF FINANCIAL OFFICER Officer
Transaction date
Proposed sale
Price
152.12
Quantity 13,344
Value US$2,029,949
JENSEN MICHAEL WOLFF Officer; EXECUTIVE VP CHIEF LEGAL OFFICER Officer
Transaction date
Proposed sale
Price
152.12
Quantity 13,344
Value US$2,029,949
SPROGOE KENNETT Officer; EXECUTIVE VP HEAD OF RESEARCH AND PRODUCT DEV Officer
Transaction date
Proposed sale
Price
152.12
Quantity 7,719
Value US$1,174,249
1.6
JENSEN FLEMMING STEEN Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY Officer
Transaction date
Proposed sale
Price
152.12
Quantity 7,719
Value US$1,174,249
MIKKELSEN JAN MOLLER Officer; PRESIDENT CHIEF EXECUTIVE OFFICER Officer
Transaction date
Proposed sale
Price
155.14
Quantity 7,800
Value US$1,210,089
SINGEL STINA Officer; EVP HEAD OF CLINICAL DEVELOPMENT CMO ONCOLOGY Officer
Transaction date
Proposed sale
Price
155.20
Quantity 2,729
Value US$423,542
SMITH SCOTT THOMAS Officer Officer
Transaction date
Proposed sale
Price
154.27
Quantity 10,000
Value US$1,542,671
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-09 2026-09-08 S Sale

SVP & PAO

Officer
2,440 +8.8%
389.81
US$4,593,162
2,440 +8.8% 389.81 US$4,593,162
2026-09-08 2026-09-08 PrS Proposed sale

Officer

Officer
15,039
415.89
US$1,408,326
15,039 415.89 US$1,408,326
2026-09-03 2026-09-02 S Sale Non-Executive Director
54,068 -31.5%
396.67
US$1,174,717
54,068 -31.5% 396.67 US$1,174,717
2026-09-02 2026-09-02 PrS Proposed sale

Director

Non-Executive Director
236
264.13
US$62,335
236 264.13 US$62,335
2026-08-18 2026-08-14 B Purchase Non-Executive Director
900 +45.0%
246.91
US$222,219
900 +45.0% 246.91 US$222,219
2026-08-18 2026-08-14 B Purchase Non-Executive Director
1,100 +122.2%
245.85
US$270,435
1,100 +122.2% 245.85 US$270,435
2026-06-02 2026-06-02 B Purchase

EVP & Chief Financial Officer

Officer
100 +2.3%
219.00
US$21,900
100 +2.3% 219.00 US$21,900
2026-06-01 2026-05-29 B Purchase

EVP & Chief Financial Officer

Officer
250 +6.2%
223.32
US$55,830
250 +6.2% 223.32 US$55,830
2026-06-01 2026-05-29 B Purchase Non-Executive Director
100 +12.5%
223.50
US$22,350
100 +12.5% 223.50 US$22,350
2026-06-01 2026-05-29 B Purchase Non-Executive Director
200 +33.3%
222.30
US$44,460
200 +33.3% 222.30 US$44,460
2026-06-01 2026-05-29 B Purchase Non-Executive Director
200 +50.0%
223.76
US$44,752
200 +50.0% 223.76 US$44,752
2026-05-27 2026-05-26 B Purchase Non-Executive Director
200 +100.0%
239.37
US$47,874
200 +100.0% 239.37 US$47,874
2026-05-27 2026-05-26 B Purchase Non-Executive Director
200 +inf%
236.24
US$47,247
200 +inf% 236.24 US$47,247
2026-05-12 2026-05-11 S Sale

See Remarks

Officer
19,460 -100.0%
238.49
US$4,641,021
19,460 -100.0% 238.49 US$4,641,021
2026-05-11 2026-05-11 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
19,460
238.49
US$4,641,022
19,460 238.49 US$4,641,022
2026-03-09 2026-03-09 PrS Proposed sale

Officer

Officer
3,782
240.00
US$907,680
3,782 240.00 US$907,680
2026-03-06 2026-03-06 PrS Proposed sale

Officer

Officer
10,000
237.53
US$2,375,308
10,000 237.53 US$2,375,308
2026-03-06 2026-03-05 PrS Proposed sale

Officer

Officer
10,000
240.00
US$2,400,000
10,000 240.00 US$2,400,000
2026-03-05 2026-03-05 PrS Proposed sale

Officer

Officer
5,583
235.81
US$1,316,555
5,583 235.81 US$1,316,555
2026-03-05 2026-03-05 PrS Proposed sale

Officer

Officer
10,000
240.00
US$2,400,000
10,000 240.00 US$2,400,000
2026-03-05 2026-03-05 PrS Proposed sale

CEO; Officer

Officer
94,000
241.38
US$22,689,720
94,000 241.38 US$22,689,720
2026-03-04 2026-03-04 PrS Proposed sale

Officer

Officer
10,105
236.34
US$2,388,195
10,105 236.34 US$2,388,195
2026-03-04 2026-03-04 PrS Proposed sale

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
7,290
239.22
US$1,743,914
7,290 239.22 US$1,743,914
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
1,800
242.09
US$435,762
1,800 242.09 US$435,762
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
1,800
242.09
US$435,762
1,800 242.09 US$435,762
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF FINANCIAL OFFICER

Officer
18,349
242.09
US$4,442,109
18,349 242.09 US$4,442,109
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTUVE VP CHIEF LEGAL OFFICER

Officer
18,349
242.09
US$4,442,109
18,349 242.09 US$4,442,109
2026-03-02 2026-03-02 PrS Proposed sale

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
6,872
242.09
US$1,663,642
6,872 242.09 US$1,663,642
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER

Officer
10,800
242.09
US$2,614,572
10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
2,100
242.09
US$508,389
2,100 242.09 US$508,389
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
2,100
242.09
US$508,389
2,100 242.09 US$508,389
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF RESEARCH AND PROD DEVELOPMENT

Officer
10,800
242.09
US$2,614,572
10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
10,800
242.09
US$2,614,572
10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
2,100
242.09
US$508,389
2,100 242.09 US$508,389
2026-01-13 2026-01-13 PrS Proposed sale

Officer; PRESIDENT CEO

Officer
86,860
211.99
US$18,413,631
86,860 211.99 US$18,413,631
2025-12-04 2025-12-04 PrS Proposed sale

Officer

Officer
10,000
208.10
US$2,081,019
10,000 208.10 US$2,081,019
2025-12-02 2025-12-02 PrS Proposed sale

CEO; Officer

Officer
100,000
210.85
US$21,085,000
100,000 210.85 US$21,085,000
2025-12-02 2025-12-02 PrS Proposed sale

Officer

Officer
10,000
209.32
US$2,093,222
10,000 209.32 US$2,093,222
2025-12-02 2025-12-02 PrS Proposed sale

Officer

Officer
10,000
205.85
US$2,058,454
10,000 205.85 US$2,058,454
2025-12-01 2025-12-01 PrS Proposed sale

Officer

Officer
218
209.54
US$45,680
218 209.54 US$45,680
2025-09-09 2025-09-09 PrS Proposed sale

Officer

Officer
5,000
203.70
US$1,018,503
5,000 203.70 US$1,018,503
2025-08-29 2025-08-29 PrS Proposed sale

Officer

Officer
5,000
193.00
US$965,000
5,000 193.00 US$965,000
2025-08-27 2025-08-27 PrS Proposed sale

Officer

Officer
3,036
193.94
US$588,814
3,036 193.94 US$588,814
2025-08-20 2025-08-20 PrS Proposed sale

President and Chief Executive Officer

Officer
3,000
192.80
US$578,385
3,000 192.80 US$578,385
2025-08-15 2025-08-15 PrS Proposed sale

Officer

Officer
9,375
194.82
US$1,826,403
9,375 194.82 US$1,826,403
2025-08-14 2025-08-14 PrS Proposed sale

Officer

Officer
25,000
191.60
US$4,789,998
25,000 191.60 US$4,789,998
2025-08-13 2025-08-13 PrS Proposed sale

Director; Non-Executive Director

Non-Executive Director
2,158
191.07
US$412,319
2,158 191.07 US$412,319
2025-08-13 2025-08-13 PrS Proposed sale

Officer

Officer
10,000
191.32
US$1,913,225
10,000 191.32 US$1,913,225
2025-08-12 2025-08-12 PrS Proposed sale

Officer

Officer
10,000
192.57
US$1,925,734
10,000 192.57 US$1,925,734
2025-05-12 2025-05-12 PrS Proposed sale

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
2,018
154.80
US$312,384
2,018 154.80 US$312,384
2025-05-07 2025-05-07 PrS Proposed sale

Officer

Officer
10,938
162.20
US$1,774,164
10,938 162.20 US$1,774,164
2025-05-07 2025-05-06 PrS Proposed sale

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
4,204
166.61
US$700,412
4,204 166.61 US$700,412
2025-05-06 2025-05-06 PrS Proposed sale

Officer

Officer
10,000
170.05
US$1,700,485
10,000 170.05 US$1,700,485
2025-05-05 2025-05-05 PrS Proposed sale

Officer

Officer
4,386
170.99
US$749,948
4,386 170.99 US$749,948
2025-03-07 2025-03-07 PrS Proposed sale

Officer

Officer
4,000
146.46
US$585,846
4,000 146.46 US$585,846
2025-03-06 2025-03-06 PrS Proposed sale

Officer

Officer
10,000
152.39
US$1,523,933
10,000 152.39 US$1,523,933
2025-03-06 2025-03-06 PrS Proposed sale

Officer

Officer
1,614
152.25
US$245,735
1,614 152.25 US$245,735
2025-03-05 2025-03-05 PrS Proposed sale

Officer; PRESIDENT CHIEF EXECUTIVE OFFICER

Officer
7,789
155.13
US$1,208,292
7,789 155.13 US$1,208,292
2025-03-05 2025-03-05 PrS Proposed sale

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
2,254
155.01
US$349,403
2,254 155.01 US$349,403
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP AND CHIEF COMMERCIAL OFFICER

Officer
2,222
152.12
US$338,021
2,222 152.12 US$338,021
2025-03-04 2025-03-04 PrS Proposed sale

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
2,828
152.12
US$430,208
2,828 152.12 US$430,208
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,006
152.12
US$153,037
1,006 152.12 US$153,037
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,006
152.12
US$153,037
1,006 152.12 US$153,037
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,470
152.12
US$223,623
1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,470
152.12
US$223,623
1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,470
152.12
US$223,623
1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF CLINICAL DEV ONCOLOGY

Officer
13,344
152.12
US$2,029,949
13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF FINANCIAL OFFICER

Officer
13,344
152.12
US$2,029,949
13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF LEGAL OFFICER

Officer
13,344
152.12
US$2,029,949
13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER

Officer
7,719
152.12
US$1,174,249
7,719 152.12 US$1,174,249
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF RESEARCH AND PRODUCT DEV

Officer
7,719
152.12
US$1,174,249
7,719 152.12 US$1,174,249
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
7,719
152.12
US$1,174,249
7,719 152.12 US$1,174,249
2025-03-03 2025-03-03 PrS Proposed sale

Officer; PRESIDENT CHIEF EXECUTIVE OFFICER

Officer
7,800
155.14
US$1,210,089
7,800 155.14 US$1,210,089
2025-02-21 2025-02-20 PrS Proposed sale

Officer; EVP HEAD OF CLINICAL DEVELOPMENT CMO ONCOLOGY

Officer
2,729
155.20
US$423,542
2,729 155.20 US$423,542
2025-02-20 2025-02-20 PrS Proposed sale

Officer

Officer
10,000
154.27
US$1,542,671
10,000 154.27 US$1,542,671